Paper18367671
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes.
Wilkinson SR and 4 others. Proc Natl Acad Sci U S A, 2008. Cited by 357 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Papers, record 18367671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18367671
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance | Major topic |
| Nifurtimox | Major topic |
| Nitroimidazoles | Major topic |
| Trypanocidal Agents | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Gene Expression Regulation | |
| Genome, Protozoan | |
| Mitochondria | |
| Nitroreductases | |
| Phenotype | |
| Protozoan Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9952319 | Enzymatic reduction studies of nitroheterocycles. | Biochem Pharmacol | 1999 | https://conductscience.org/library/papers/9952319 | PubMed |
| 2 | 16559085 | Mode of action of nitrofurazone. | J Bacteriol | 1970 | https://conductscience.org/library/papers/16559085 | PubMed |
| 3 | 9377478 | A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata. | Biol Chem | 1997 | https://conductscience.org/library/papers/9377478 | PubMed |
| 4 | 2406032 | Sensitivity of parasites to free radical damage by antiparasitic drugs. | Chem Biol Interact | 1990 | https://conductscience.org/library/papers/2406032 | PubMed |
| 5 | 8259135 | Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages. | Mol Biochem Parasitol | 1993 | https://conductscience.org/library/papers/8259135 | PubMed |
| 6 | 12417633 | A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. | J Exp Med | 2002 | https://conductscience.org/library/papers/12417633 | PubMed |
| 7 | 12811546 | Nitroheterocyclic drugs with broad spectrum activity. | Parasitol Res | 2003 | https://conductscience.org/library/papers/12811546 | PubMed |
| 8 | 3247312 | Evidence for the involvement of a nitrenium ion in the covalent binding of nitrofurazone to DNA. | Pharm Res | 1988 | https://conductscience.org/library/papers/3247312 | PubMed |
| 9 | 4941089 | Breakage of bacterial DNA by nitrofuran derivatives. | Cancer Res | 1971 | https://conductscience.org/library/papers/4941089 | PubMed |
| 10 | 17145786 | Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17145786 | PubMed |
| 11 | 16413403 | Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei. | Free Radic Biol Med | 2006 | https://conductscience.org/library/papers/16413403 | PubMed |
| 12 | 17446142 | Discovery of ubiquinone (coenzyme Q) and an overview of function. | Mitochondrion | 2007 | https://conductscience.org/library/papers/17446142 | PubMed |
| 13 | 3130683 | Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. | Trans R Soc Trop Med Hyg | 1987 | https://conductscience.org/library/papers/3130683 | PubMed |
| 14 | 9662705 | Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. | Mol Biochem Parasitol | 1998 | https://conductscience.org/library/papers/9662705 | PubMed |
| 15 | 16182389 | Tagging a T. brucei RRNA locus improves stable transfection efficiency and circumvents inducible expression position effects. | Mol Biochem Parasitol | 2005 | https://conductscience.org/library/papers/16182389 | PubMed |
| 16 | 11020276 | Crystal structure of FMN-dependent nitroreductase from Escherichia coli B: a prodrug-activating enzyme. | J Med Chem | 2000 | https://conductscience.org/library/papers/11020276 | PubMed |
| 17 | 6327675 | Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria. Evidence of an outer membrane-located nitroreductase. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6327675 | PubMed |
| 18 | 338576 | Genetics of nitrofurazone resistance in Escherichia coli. | J Bacteriol | 1978 | https://conductscience.org/library/papers/338576 | PubMed |
| 19 | 16756485 | Energy converting NADH:quinone oxidoreductase (complex I). | Annu Rev Biochem | 2006 | https://conductscience.org/library/papers/16756485 | PubMed |
| 20 | 2614608 | Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. | J Parasitol | 1989 | https://conductscience.org/library/papers/2614608 | PubMed |
Cited by218
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 357 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42603444 | Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay. | Int J Parasitol Drugs Drug Resist | 2026 | https://conductscience.org/library/papers/42603444 | PubMed |
| 42454824 | Advances and challenges in the search for new treatments for Chagas disease. | Mem Inst Oswaldo Cruz | 2026 | https://conductscience.org/library/papers/42454824 | PubMed |
| 42401745 | A cell surface transporter mediates phenanthridine resistance in African trypanosomes. | NPJ Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42401745 | PubMed |
| 42371586 | Pathogenic Significance of Trypanosomatids: Progress in Drug Resistance, Control Strategies, and Artificial Intelligence. | Interdiscip Perspect Infect Dis | 2026 | https://conductscience.org/library/papers/42371586 | PubMed |
| 42358646 | Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance. | J Pharm Pharm Sci | 2026 | https://conductscience.org/library/papers/42358646 | PubMed |
| 42307013 | Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part III. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/42307013 | PubMed |
| 42221541 | Trypanosomatid parasites, translational research in a One Health, One World environment. | Front Chem | 2026 | https://conductscience.org/library/papers/42221541 | PubMed |
| 42108536 | A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42108536 | PubMed |
| 42062475 | Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination. | NPJ Antimicrob Resist | 2026 | https://conductscience.org/library/papers/42062475 | PubMed |
| 41932358 | Targeting Kinetoplastid Parasites with ProTide Prodrugs: A Proof-of-Concept Study. | ChemMedChem | 2026 | https://conductscience.org/library/papers/41932358 | PubMed |
| 41599779 | Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599779 | PubMed |
| 41394106 | Differential antioxidant enzyme profiles reveal early molecular signatures of virulence in Trypanosoma cruzi DTU-TcI and DTU-TcVI strains. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41394106 | PubMed |
| 41355869 | Synthesis and evaluation of nitroheterocyclic aromatic adamantane amides with trypanocidal activity. Part II. | RSC Med Chem | 2026 | https://conductscience.org/library/papers/41355869 | PubMed |
| 41182628 | A Single-Cell Methodology for Energy Metabolism Analysis in Parasitic Protozoa. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41182628 | PubMed |
| 41134857 | Fexinidazole results in specific effects on DNA synthesis and DNA damage in the African trypanosome. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/41134857 | PubMed |
| 41011282 | Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011282 | PubMed |
| 40941913 | Buddleja globosa Leaf Methanolic Extract Acts Against Trypanosoma cruzi Parasites by Inducing Mitochondrial Inner Membrane Hyperpolarization. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/40941913 | PubMed |
| 40934206 | Glycosomal ABC transporter 3 (GAT3) deletion enhances the oxidative stress responses and reduces the infectivity of Trypanosoma cruzi. | PLoS Negl Trop Dis | 2025 | https://conductscience.org/library/papers/40934206 | PubMed |
| 40863176 | Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against Trypanosoma cruzi and Leishmania mexicana. | Metabolites | 2025 | https://conductscience.org/library/papers/40863176 | PubMed |
| 40781240 | Lipid-mediated gating of a miniature mechanosensitive MscS channel from Trypanosoma cruzi. | Nat Commun | 2025 | https://conductscience.org/library/papers/40781240 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18367671
GET https://conductscience.org/api/papers/v1/18367671/references?page=2